高风险研究中欺骗行为的可允许性
The Permissibility of Deception in Riskier Research.
作者信息
Wendler David
机构信息
Head of the section on research ethics at the National Institutes of Health (NIH) Clinical Center.
出版信息
Ethics Hum Res. 2020 Mar;42(2):34-40. doi: 10.1002/eahr.500046.
The use of deception is typically prohibited in studies that pose greater than minimal risk overall. This approach prevents researchers from using deception to conceal significant risks or to deceive participants about the purpose, potential benefits, or other aspects of a study that are relevant to deciding whether to accept such risks. Yet this approach also mistakenly blocks appropriate research. In particular, it keeps researchers from using deception in studies that pose greater than minimal risk, even when participants are informed accurately about the risks and other aspects of the study that are relevant to deciding whether to participate. Rather than prohibiting deception when the overall study poses greater than minimal risk, policies should prohibit deception when the aspect of the study about which participants are deceived poses greater than minimal risk.
在总体风险大于最小风险的研究中，通常禁止使用欺骗手段。这种做法防止研究人员利用欺骗来隐瞒重大风险，或在研究的目的、潜在益处或与决定是否接受此类风险相关的其他方面欺骗参与者。然而，这种做法也错误地阻碍了适当的研究。特别是，它使研究人员无法在风险大于最小风险的研究中使用欺骗手段，即使参与者已被准确告知与决定是否参与相关的研究风险和其他方面。政策不应在总体研究风险大于最小风险时禁止欺骗，而应在研究中被欺骗的方面风险大于最小风险时禁止欺骗。
Zotero 插件